Sector News

Bayer sells further stake in Covestro for 1 billion euros

September 29, 2017
Chemical Value Chain

German drugs and pesticides group Bayer said on Friday it had further reduced to just under 25 percent its holding in Covestro, the plastics producer which it demerged in 2015, by selling a 6.9 percent stake for 1 billion euros ($1.2 billion).

Bayer, which is trying to complete its $66 billion takeover of U.S. seeds giant Monsanto (MON.N) by the end of the year, declined to name the buyers but said they would be bound by a lock-up agreement to not sell the shares until at least Dec 11.

The sale was not an open market transaction and therefore meets a lock-up agreement from Sept 13, when Bayer agreed not to place further shares on the open market for 90 days.

Before Friday’s transaction Bayer had already sold three separate blocks of shares in Covestro this year for 3.7 billion euros, and also raised 1 billion euros in for bonds that it can pay back with Covestro shares.

“Through the move, we have taken a major step toward our goal of achieving full separation from Covestro in the medium term,” Chief Executive Werner Baumann said in a statement.

A spokesman for Bayer said there would be no immediate changes to the Covestro supervisory board as a result of the sale, which takes Bayer’s stake down to 24.6 percent.

The move means Bayer has ceded control of Covestro and will see it needing to revise its group outlook to take into account of it now being classed as a discontinued operation.

Bayer is due to report third-quarter results on Oct 26.

The Bayer Pension Trust continues to hold a 8.9 percent stake in Covestro.

By Ludwig Burger and Victoria Bryan;

Source: Reuters

comments closed

Related News

December 3, 2022

Corteva to acquire Stoller Group for $1.2 billion

Chemical Value Chain

Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.

December 3, 2022

OMV introduces new corporate structure to drive sustainable growth and innovation

Chemical Value Chain

OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.

December 3, 2022

What does the current downturn in industrial manufacturing mean for executives searching for a senior role in the chemicals industry?

Chemical Value Chain

The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.